References
- Hardy J. A hundred years of Alzheimer’s disease research. Neuron 2006;52:3–13.
- Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer’s disease. J Biol Chem 1996;271:18295–18298.
- Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002;30:552–557.
- Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, Bowie JU. Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 2005;102:14278–14283.
- Gralle M, Ferreira ST. Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 2007;82:11–32.
- Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer’s disease. Neurobiol Aging 2005;26:1235–1244.
- Jarrett JT, Lansbury PT Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 1993;73:1055–1058.
- Soto C, Brañes MC, Alvarez J, Inestrosa NC. Structural determinants of the Alzheimer’s amyloid beta-peptide. J Neurochem 1994;63:1191–1198.
- Findeis MA. The role of amyloid beta peptide 42 in Alzheimer’s disease. Pharmacol Ther 2007;116:266–286.
- Soto C, Castano E, Frangione B, Inestrosa NC. The α-helical to β-strand transition in the N-terminal fragment of the amyloid β-peptide modulates amyloid formation. J Biol Chem 1995;266:4025–4028.
- Poulos TL, Li H, Shimizu H, Flinspach M, Jamal J, Yang W, Xian M, Cai T, Zhong WE, Jia Q, Wang PG. The novel binding mode of N-Alkyl-N’-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry 2002;41:3868–13875.
- Padayachee ER, Whiteley CG. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer’s disease. Biochim Biophys Acta 2011;1810:1136–1140.
- Padayachee E, Ngqwala NP, Whiteley CG. Association of β-amyloid peptide fragments with neuronal nitric oxide synthase: Implications in the etiology of Alzheimers disease. Enz Inhib Med Chem 2011 doi: 10.3109/14756366.2011.590805
- Mohlake P, Whiteley CG. Arginine metabolising enzymes as therapeutic tools for Alzheimer’s disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol Neurobiol 2010;41:149–158.
- Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN et al. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer’s disease. Brain Res 2007;1148:243–248.
- Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007;8:766–775.
- Celsi F, Ferri A, Casciati A, D’Ambrosi N, Rotilio G, Costa A et al. Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem Int 2004;44:25–33.
- Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J Neurochem 2005;93:953–962.
- McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049–6055.
- Carloni P, Blichl PE, Parrinello M. Electronic structure of the Cu-Zn superoxide dismutase active site and its interactions with the substrate. J Phys Chem 1995;99:1338–1348.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
- Barra D, Schinina ME, Simmaco M, Bannister JV, Bannister WH, Rotilio G et al. The primary structure of human liver manganese superoxide dismutase. J Biol Chem 1984;259:12595–12601.
- Anantharaman M, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK et al. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer’s disease. Am J Pathol 2006;168:1608–1618.
- Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci 1998;158:47–52.